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Definition 
  
Cirrhosis is a clinical syndrome at the terminal stages of 
chronic hepatitis  in which healthy liver tissue is replaced 
with scar tissue, eventually preventing the liver from 
functioning properly, that leads to portal hypertension, in 
early stages often without explicating  symptoms, but 
later with its worsening patient   become tired, weak, 
itchy, more and more often has swelling in the lower legs, 
develops yellow skin, builds up fluid in the abdomen, or 
develops spider-like blood vessels on the skin, bleeding 
from dilated (esophageal, stomachic, hemoroidal) veins, 
often with hepatic encephalopathy, and liver cancer.   
 en.wikipedia.org/wiki/Cirrhosis 
Classification 
World Health Organization (Anthony P.P. et al. J Clin Pathol 31:395,1978) 
• Morphologic 
– Macronodular    
– Micronodular    
– Mixed 
• Histologic 
– Portal 
– Post-necrotic 
– Post Hepatitic 
–  Biliary 
– Congestive 
• Etiologic agents 
– Genetic (i.e. biliary atresia, 
cystic fibrosis, Wilson 
Disease) 
– Toxic 
– Infectious 
– Biliary 
– Vascular (i.e. congestive heart 
failure) 
– Cryptogenic (which the cause 
is unknown) 
– Fatty liver 
 
meddean.luc.edu/lumen/MedED/orfpath/cirhosis.htm 
 Epidemiology 
  The Epidemiology of Cirrhosis in the United States 
• The prevalence of cirrhosis in the United States is 
approximately 0.27%, corresponding to 633,323 adults.  
• Sixty-nine percent report that they were unaware of having 
liver disease.  
• The prevalence is higher in non-Hispanic blacks and 
Mexican Americans, those living below the poverty level, 
and those with less than a 12th grade education.  
• Diabetes, alcohol abuse, hepatitis C and B, male sex, and 
older age are all independently associated with cirrhosis, 
with a population attributable fraction of 53.5% from viral 
hepatitis (mostly hepatitis C), diabetes, and alcohol abuse.  
• Mortality is 26.4% per 2-year interval in cirrhosis compared 
with 8.4% in propensity-matched controls. 
• Cirrhosis is the 12th leading cause of death in the United 
States. 
aafp.org/afp/2011/1215/p1353.html  ncbi.nlm.nih.gov/pubmed/25291348 
 Epidemiology 
  
Probability of death from cirrhosis among 15-49 year olds, 2013 
humanosphere.org/science/2014/12/cirrhosis-its-not-just-for-heavy-drinkers-anymore/ 
Etiology 
  
Etiological profile of cirrhosis of liver from North-East India. 
oghr.org/articles/2015/4/1/images/OncGasHepRep_2015_4_1_8_139623_u1.jpg 
Mechanisms  
  
• Injury 
• Degeneration  
• Fibrosis  
• Formation of fibro-vascular membranes 
• Parenchymal dissection into nodules 
• Rearrangement of blood circulation 
cirrhosis 
meddean.luc.edu/lumen/MedED/orfpath/cirhosis.htm 
 History 
• The clinical features of cirrhosis have been 
known since ancient times.  
• The Ebbers papyrus written around 2600 BC 
describes ascites, which was known to be 
associated with a “hardness of the liver” and 
excessive alcohol consumption. 
aafp.org/afp/2011/1215/p1353.html 
 Clinical investigation   
• Cirrhosis is frequently indolent, asymptomatic and 
unsuspected until complications of liver disease 
present: a sizable proportion of these patients 
never come to clinical attention, and previously 
undiagnosed cirrhosis is still frequently found at 
autopsy. 
• However, initial clinical presentation of patients 
with decompensated cirrhosis is still common and 
is characterized by the presence of dramatic and 
life-threatening complications, such as variceal 
hemorrhage, ascites, spontaneous bacterial 
peritonitis, or hepatic encephalopathy. 
ncbi.nlm.nih.gov/pmc/articles/PMC2271178/ 
 Clinical investigation 
Portal hypertension 
  Portal hypertension: hepatic venous pressure gradient (HVPG) 
greater than or equal to 5mm Hg and is considered to be 
clinically significant when HVPG exceeds 10 to 12 mm Hg. 
The main symptoms and complications: 
• Ascites (an accumulation of fluid in the abdomen). 
• Dilated veins in the anterior abdominal wall. 
• Splenomegaly.  
• Encephalopathy or confusion and forgetfulness caused by 
poor liver function. 
• Reduced levels of platelets, blood cells that help form blood 
clots, or white blood cells, the cells that fight infection. 
• Gastrointestinal bleeding marked by black, tarry stools or 
blood in the stools, or vomiting of blood due to the 
spontaneous rupture and hemorrhage from varices. 
webmd.com/digestive-disorders/digestive-diseases-portalen.wikipedia.org/wiki/Portal_hypertension 
 Clinical investigation 
Symptoms 
  
• Decreased appetite 
• Nose bleeds 
• Jaundice (yellow 
discoloration) 
• Small spider-shaped 
arteries underneath the 
skin 
• Weight loss 
• Anorexia 
• Itchy skin 
• Weakness 
• Confusion and difficulty 
thinking clearly (hepatic 
encephalopathy) 
• Abdominal swelling 
(ascites: free fluid in 
the peritoneal cavity) 
• Swelling of the legs 
(edema) 
• Impotence 
• Gynecomastia (when 
males start to develop 
breast tissue) 
 
healthline.com/health/cirrhosis#Symptoms4 
 Clinical investigation 
Activity 
  
Activity is assessed by extent of cell damage, inflammatory reaction within the 
scar tissue, piecemeal necrosis along fibrous septa, edema of the septa and 
changes in the parenchymal nodules such as necrosis and cholestasis.  
 
Activity grades 
• Inactive 
No inflammation and intact limiting plates around septa which are fibrotic.  
• Slight 
Mild inflammation; segmental erosion of limiting plates. 
• Moderate 
Moderate inflammation and damage of limiting plates.  
• Severe 
Marked inflammation, extensive damage of limiting plates, piecemeal 
necrosis and parenchymal damage (necrosis, cholestasis, dysplasia, 
malignant transformation.  
meddean.luc.edu/lumen/MedED/orfpath/cirhosis.htm 
Complications 
About one third of cirrhosis are compensated and, do not produce any 
clinical symptoms and are accidentally discovered during a medical 
examination or an operation or at autopsy. The rest are decompensated and 
produce complications mainly due to liver failure and portal hypertension. 
• Edema and ascites. 
• Varices (in the anterior abdominal 
wall, esophageal, hemorroidal). 
• Portal Vein Thrombosis. 
• Digestive Hemorrhages. 
• Jaundice 
• Hepatic encephalopathy (confusion 
due to the effects of blood toxins on 
the brain) 
• Impaired Coagulation 
• Anemia 
• Infection 
• Infarction Of Nodules  
• Bruising (due to low platelet count 
and/or poor clotting) 
• Bleeding (due to decreased 
clotting proteins) 
• Sensitivity to medications (the liver 
processes medications in the body) 
• Kidney failure 
• Liver cancer 
• Insulin resistance and type 2 
diabetes 
• Gallstones (interference with bile 
flow can cause bile to harden and 
form stones)  
• Enlarged spleen (splenomegaly) 
healthline.com/health/cirrhosis#Complications6meddean.luc.edu/lumen/MedED/orfpath/cirhosis.htm 
 Clinical investigation 
Dilated veins in the anterior abdominal wall 
  
Caput medusae 
or palm tree sign, is 
the appearance of 
distended and 
engorged superficial 
epigastric veins due 
to portal 
hypertension, which 
are seen radiating 
from the umbilicus 
across the 
abdomen. 
image.slidesharecdn.com/portal-090805013712-phpapp01/95/portal-10-728.jpg?cb=1249436242 en.wikipedia.org/wiki/Caput_medusae 
 Clinical investigation 
Decompensated cirrhosis 
  
• In patients with previously stable cirrhosis, 
decompensation may occur due to various causes, 
such as constipation, infection (of any source), 
increased alcohol intake, medication, bleeding 
from esophageal varices or dehydration.   
• Patients with decompensated cirrhosis generally 
require admission to hospital, with close 
monitoring of the fluid balance, mental status, and 
emphasis on adequate nutrition and medical 
treatment.  
en.wikipedia.org/wiki/Cirrhosis 
 Clinical investigation 
West Haven Criteria Grading System of Hepatic 
Encephalopathy 
aafp.org/afp/2011/1215/p1353.html 
GRADE DESCRIPTION  
1 Trivial lack of awareness; euphoria or anxiety; 
shortened attention span; impaired performance of 
addition or subtraction 
2 
Lethargy or apathy; minimal disorientation for time 
or place; subtle personality change; inappropriate 
behavior 
3 
Somnolence to semistupor, but responsive to verbal 
stimuli; confusion; gross disorientation 
4 
Coma (unresponsive to verbal or noxious stimuli) 
 Clinical investigation 
  
Liver Cirrhosis 
 Diagnosis 
  
Diagnosis is made by assessing an individual's 
symptoms, physical exam, and medical history, 
in conjunction with blood tests, liver biopsy, 
and imaging.  
 en.wikipedia.org/wiki/Hepatitis 
 Diagnosis 
Laboratory testing  
  • Complete blood count. • Liver disease–associated blood tests (e.g., aspartate aminotransferase [AST], 
alanine aminotransferase [ALT], bilirubin, alkaline phosphatase [ALP]) 
• Coagulation studies (prothrombin time [PT], partial thromboplastin time 
[PTT], international normalized ratio [INR]): Prolonged INR is suggestive of 
impaired hepatic synthetic function. 
• Albumin: hypoalbuminemia is common (impaired hepatic synthetic 
function). 
• Blood urea nitrogen, creatinine, and electrolytes. 
• Arterial blood gas (ABG) and pH measurements. 
• Hepatic and viral hepatitis serologies, particularly hepatitis B and C 
serologies. 
• Antinuclear antibody, antimitochondrial antibody, antismooth muscle 
antibody. 
• Iron indices. 
• Alpha1-antitrypsin deficiency. 
• Ceruloplasmin, 24-hour urinary copper: Consider this test only in individuals 
aged 3-40 years who have unexplained hepatic, neurologic, or psychiatric 
disease. 
emedicine.medscape.com/article/182098-overview 
 Diagnosis 
Liver chemistry test 
  
 en.wikipedia.org/wiki/Hepatitis 
Liver chemistry test Clinical implication of abnormality 
Alanine transaminase (ALT) 
Hepatocellular damage  
Aspartate 
transaminase (AST) 
Lactate dehydrogenase 
Bilirubin 
Cholestasis  
Alkaline phosphatase 
Gamma-glutamyl 
transpeptidase (GGT) 
Bile acids 
Prothrombin time 
Impaired synthetic function  
Albumin (ALB) 
 Diagnosis 
Instrumental tests 
  
• Upper endoscopy (to see if esophageal varices 
are present) 
• Ultrasound scan of the liver 
• MRI of the abdomen 
• CT scan of the abdomen 
• Liver biopsy (the definitive test for cirrhosis) 
healthline.com/health/cirrhosis#Diagnosis5 
 Diagnosis 
Imaging studies   
• Duplex Doppler 
ultrasonography of the liver 
and upper abdomen 
• Computed tomography (CT) 
scanning and/or magnetic 
resonance imaging (MRI): Can 
be used when ultrasonographic 
findings are inconclusive 
• Bleeding scan or angiography: 
Used when bleeding is obscure 
and the source is unclear 
intechopen.com/source/html/18256/media/image35.jpg emedicine.medscape.com/article/182098-overview 
 Diagnosis 
Procedures   
• Liver biopsy and histologic 
examination. 
• Hemodynamic measurement 
of the hepatic venous 
pressure gradient (HVPG): A 
criterion standard for 
assessment of portal 
hypertension. 
• Upper GI endoscopy (or, 
esophagogastroduodenoscop
y [EGD]): A criterion standard 
for assessment of portal 
hypertension. 
 emedicine.medscape.com/article/182098-overview 
 
 Large esophageal 
varices with red 
wale signs seen 
on endoscopy.  
Uphill esophageal varices. 
Barium swallow demonstrates 
multiple serpiginous filling 
defects primarily involving the 
lower one third of the 
esophagus with striking 
prominence around the 
gastroesophageal junction. The 
patient had cirrhosis secondary 
to alcohol abuse. 
 Diagnosis 
Liver biopsy   
• Biopsy is considered the gold standard for diagnosis of 
cirrhosis, and sequential histological grading of inflammation 
and staging of fibrosis can assess risk of progression. 
• A liver biopsy is obtained by either a (radiographically-guided) 
percutaneous, a transjugular or laparoscopical route.  
• A greater risk of bleeding following a biopsy has been observed 
with larger-diameter needles.  
• In suspected cirrhosis a cutting is preferred over a suction 
needle, in order to prevent tissue fragmentation. 
• Aspirin and other anti-platelet agents should be stopped at 
least a week before biopsy.  
ncbi.nlm.nih.gov/pmc/articles/PMC2271178/ 
 Clinical investigation 
  
Laparoscopy of Cirrhosis and Liver Biopsies 
 Diagnosis 
The histopathologic features   
Lobular architecture: No 
normal lobular 
architecture can be 
identified and central 
veins are hard to find. 
library.med.utah.edu/WebPath/jpeg4/LIVER014.jpg meddean.luc.edu/lumen/MedED/orfpath/cirhosis.htm 
High magnification  
micrograph of 
a liver with cirrhosis. 
Microscopically with 
cirrhosis, the regenerative 
nodules of hepatocytes are 
surrounded by fibrous 
connective tissue that 
bridges between portal 
tracts. 
Treatment 
Lifestyle modifications   
  
• Lifestyle modifications are 
strongly recommended for 
patients with chronic 
hepatitis. 
• Management of patients 
with liver cirrhosis and 
ascites but without 
hemorrhage includes a 
low-sodium diet and 
diuretics. 
emedicine.medscape.com/article/182098-overview 
MyPyramid 
Treatment  
  
• Treatment for cirrhosis varies based on what caused it and 
how far the disorder has progressed. 
• There is evidence that causal treatment may even reverse 
cirrhosis, although in some of the reports sampling variability 
cannot be excluded. 
 
 
ncbi.nlm.nih.gov/pmc/articles/PMC2271178/ 
Treatment 
Medications and other approaches  
  
• Beta blockers or nitrates (for portal hypertension). 
• Quitting drinking (if the cirrhosis is caused by alcohol). 
• Often diuretics, antibiotics, laxatives and/or enemas, 
thiamine and occasionally steroids, acetylcysteine 
and pentoxifylline.  
• Lactulose and a low protein diet (to treat encephalopathy). 
• Banding procedures (used to control bleeding from 
esophageal varices). 
• Hemodialysis (to purify the blood of those in kidney failure). 
• Liver transplantation is an option of last resort, when other 
treatments fail. 
 
healthline.com/health/cirrhosis#Treatment7 
Treatment 
Variceal bleeding 
   
PREVENTION 
 
 
TREATMENT 
 
Non selective beta blockers 
Variceal band ligation 
Acute: 
 Resuscitation 
 Vasocontrictors 
 Sclerotherapy 
 Band Ligation 
 TIPSS 
 Surgical Shunts 
  
Chronic: 
 Variceal obliteration 
 TIPS 
 Surgical Shunts 
ncbi.nlm.nih.gov/pmc/articles/PMC2271178/ 
Treatment 
Ascites  
  
ncbi.nlm.nih.gov/pmc/articles/PMC2271178/ 
 
PREVENTION 
 
 
TREATMENT 
Low Na diet Low Na diet 
Diuretics 
Large volume paracentesis 
TIPSS (transjugular 
intrahepatic porto-systemic 
shunt) 
(LeVeen / Denver shunts) 
Treatment 
Renal failure  
  
ncbi.nlm.nih.gov/pmc/articles/PMC2271178/ 
 
PREVENTION 
 
 
TREATMENT 
Avoid hypovolemia Discontinue diuretics 
Rehydration 
Albumin infusion 
Hepatorenal syndrome 
Add Terlipressin or Midodrine 
(Noradrenaline) and 
Somatostatin (Octreotide) 
Treatment 
Spontaneous bacterial peritonitis  
  
ncbi.nlm.nih.gov/pmc/articles/PMC2271178/ 
 
PREVENTION 
 
 
TREATMENT 
Treat ascites Early diagnosic paracentesis: 
 Neutrophils >250/cc → 
 antibiotics iv 
 Secondary prophlaxis with a 
po antibiotic such as 
Levofloxacin 
Treatment 
Encephalopathy  
  
ncbi.nlm.nih.gov/pmc/articles/PMC2271178/ 
 
PREVENTION 
 
 
TREATMENT 
Avoid precipitants Treat precipitating factors: 
 Infection 
 Bleeding 
 Electrolyte imbalance 
 Sedatives 
 High protein intake 
Treatment 
 Palliative care 
  
• Palliative care is specialized medical care that focuses on 
providing patients with relief from the symptoms, pain, and 
stress of a serious illness, such as cirrhosis.  
• The goal of palliative care is to improve quality of life for both 
the patient and the patient's family and it is appropriate at 
any stage and for any type of cirrhosis. 
• Especially in the later stages, people with cirrhosis experience 
significant symptoms such as abdominal swelling, itching, leg 
edema, and chronic abdominal pain which would be 
amenable for treatment through palliative care. 
• Despite proven benefit, people with cirrhosis are rarely 
referred to palliative care. 
en.wikipedia.org/wiki/Cirrhosis 
Prognosis 
 
• Prognosis depends heavily on the cirrhosis or 
complications that are causing the symptoms. 
• Serious complication of chronic hepatitis 
is liver cancer, specifically hepatocellular 
carcinoma.   
• Some cases can require a liver transplant. 
 
 en.wikipedia.org/wiki/Hepatitis 
Prophylaxis 
 
• Daily limit of one or two drinks and avoid drinking every 
day. 
• Avoid uncooked shellfish. 
• Never mix alcohol and drugs. 
• Avoid exposure to industrial chemicals, which can enter the 
bloodstream and cause liver damage. 
• Maintain a healthy, balanced diet. 
• Avoid contracting viral hepatitis.  
• Hepatitis B vaccinations and immune serum globulin shots. 
• Nonselective beta-blockers (e.g., propranolol, nadolol, 
carvedilol). 
• Vasodilators (e.g., isosorbide mononitrate [ISMN]) 
• Combination pharmacotherapy when a single agent fails. 
 
webmd.com/digestive-disorders/understanding-cirrhosis-prevention 
Clinical cases, 1 
 
A case of breast cancer in a male patient with cryptogenic cirrhosis. 
 
Breast cancer is a rare disease in men.  
Shin SR with colleagues (Departments of Internal Medicine and Pathology, 
Hallym University Kangnam Sacred Heart Hospital, Seoul, Korea) report a 
case of 53-year-old obese male, with known cryptogenic cirrhosis and 
hepatocellular carcinoma, presenting a tender mass on left breast.  
He was diagnosed with invasive intraductal carcinoma, which was consistent 
with a sporadic lesion.  
On the basis of previous literatures, obesity can be regarded as a cause for 
breast cancer even in men.  
However, there has been inconsistent data about link between liver cirrhosis 
and male breast cancer, which can be due to heterogenity in the etiology of 
cirrhosis. 
Through this case, it can be postulated that the risk for male breast cancer 
may vary according to the etiology of cirrhosis. 
 
  dgcases.docguide.com/case-breast-cancer-male-patient-cryptogenic-cirrhosis 
Clinical cases, 2 
 A case of variceal bleeding from the jejunum in liver cirrhosis. 
 
While esophagogastric varices are common manifestations of portal 
hypertension, variceal bleeding from the jejunum is a rare complication of 
liver cirrhosis. In addition, ectopic variceal bleeding occurs in the duodenum 
and at sites of previous bowel surgery in most cases, including of stomas.  
Park CW with colleagues (Department of Internal Medicine, Eulji University 
Hospital, Eulji University College of Medicine, Daejeon, Korea) report a case of 
obscure overt gastrointestinal bleeding from jejunal varices in a 55-year-old 
woman who had not previously undergone abdominal surgery, who had liver 
cirrhosis induced by the hepatitis C virus. Emergency endoscopy revealed the 
presence of esophageal varices without stigmata of recent bleeding, and no 
bleeding focus was found at colonoscopy. She continued to produce recurrent 
melena with hematochezia and received up to 21 units of packed red blood 
cells. CT angiography revealed the presence of jejunal varices, but no active 
bleeding was found. Capsule endoscopy revealed fresh blood in the jejunum. 
The patient submitted to embolization of the jejunal varices via the portal 
vein, after which she had a stable hemoglobin level and no recurrence of the 
melena.   
dgcases.docguide.com/case-variceal-bleeding-jejunum-liver-cirrhosis 
Clinical cases, 3a 
 
How can we treat a patient with liver cirrhosis (hepatitis C virus), 
hepatocellular carcinoma, and synchronous colon cancer? 
 
A 46-year-old man, diagnosed incidentally during an ultrasound (US) 
examination with a 3.5-cm HCC in segment VII related to chronic hepatitis C 
virus (HCV), was referred for liver resection. He underwent a laparoscopic 
protocol evaluation for liver cirrhosis. Liver appearance and biopsy of the left 
lobe showed Child B/C liver cirrhosis. Because he fulfilled the Milan criteria, 
was suggested an orthotopic liver transplantation (OLT). During protocol 
colonoscopy, was discovered an ulcerative sigmoid colon Ca. Three weeks 
after completing the pre-OLT assessment he underwent an OLT and was 
discharged home on day 9 on an immunosuppressive regimen of Everolimus, 
Myfortic, and Prezolone. After transplantation, the patient underwent a 
sigmoidectomy and for month thereafter received chemotherapy for colon 
Ca (6 cycles of FOLFOX:Folinic Acid+Fluorouracil+Oxaliplatin).   
dgcases.docguide.com/how-can-we-treat-patient-liver-cirrhosis-hepatitis-c-virus-hepatocellular-carcinoma-and-synchronous 
Clinical cases, 3b 
 
How can we treat a patient with liver cirrhosis (hepatitis C virus), 
hepatocellular carcinoma, and synchronous colon cancer? 
 
 One and a half years after OLT, patient was in good condition but presented 
with an increased alpha fetoprotein (a-FP) without other findings. A couple 
of months later we discovered a colon Ca recurrence and 3 small liver 
metastases. Patient underwent a bowel resection with Hartmann's 
procedure. Almost immediately after the last operation, he was found to 
suffer multiple myeloma. He underwent chemotherapy for both 
malignancies with good responses, but a few months later died of severe 
sepsis.   
dgcases.docguide.com/how-can-we-treat-patient-liver-cirrhosis-hepatitis-c-virus-hepatocellular-carcinoma-and-synchronous 
Clinical cases, 5 
 
Liver transplantation followed by pulmonary resection complicated with 
end-stage liver cirrhosis: a case report. 
 
With the recent popularization of living-donor liver transplantation (LDLT), it 
has become important to provide treatment for comorbidities in recipients. 
Taniguchi D (Anticancer Res.. 2015 Jun:35(6):3411-4.) report the case of a 
patient who was successfully treated with LDLT, followed by left upper 
lobectomy for lung cancer concomitant with decompensated liver cirrhosis. A 
67-year-old female was admitted for treatment for severe liver cirrhosis. The 
lung cancer was identified preoperatively using computed tomography. The 
patient was discharged postoperatively on day 39 without complication. Three 
months after LDLT, was performed a left upper lobectomy. The patient's 
postoperative course was uneventful and she was discharged after 11 days. 
So, an aggressive and appropriate surgical strategy, including LDLT, is an 
effective curative treatment in patients with controllable malignancy, 
concomitant with severe liver dysfunction. 
 
dgcases.docguide.com/liver-transplantation-followed-pulmonary-resection-complicated-end-stage-liver-cirrhosis-case-report 
 Clinical investigation 
  
Endstage liver disease patient 
Diagnostic and treatment guidelines 
 
• Cirrhosis: Diagnosis, Management, and 
Prevention 
•  Liver Cirrhosis 
 
 
